Plasmatic homocysteine concentration and its relationship with complications associated to diabetes mellitus (Q44205293)

30 November 2017

Plasmatic homocysteine concentration and its relationship with complications associated to diabetes mellitus (English)

1 reference

30 November 2017

Agulló-Ortuño MT

1

1 reference

30 November 2017

Albaladejo MD

2

1 reference

30 November 2017

Parra S

3

1 reference

30 November 2017

Rodríguez-Manotas M

4

1 reference

30 November 2017

Fenollar M

5

1 reference

30 November 2017

Ruíz-Espejo F

6

1 reference

30 November 2017

Tebar J

7

1 reference

30 November 2017

Martínez P

8

1 reference

30 November 2017

1 December 2002

1 reference

30 November 2017

1 reference

30 November 2017

326

1 reference

30 November 2017

1-2

1 reference

30 November 2017

105-112

1 reference

Homocysteine and cardiovascular disease in diabetes mellitus

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

Net uptake of plasma homocysteine by the rat kidney in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

Can lowering homocysteine levels reduce cardiovascular risk?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type 1 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and over.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

Serum total homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

Role of blood pressure, uric acid, and hemorheological parameters on plasma homocyst(e)ine concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

Alteration of lipoprotein(a) concentration with glycemic control in non-insulin-dependent diabetic subjects without diabetic complications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes : 5-year follow-up of the Hoorn Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

Hyperhomocysteinemia: a risk factor for ischemic stroke in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma cystatin C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

Plasma homocysteine is not increased in microalbuminuric patients with type 2 diabetes without clinical cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

Population variation and genetics of plasma homocyst(e)ine level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900287-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-8981(02)00287-5

1 reference

30 November 2017

1 reference